TF3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TF3, covering 2023-11-08 to 2023-11-08. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence of 5 Tablets of 100 mg Versus 2 Tablets of 250 mg TF3 of Tepotinib [Phase 1]